In a groundbreaking partnership, IQVIA, the global leader in clinical research services and healthcare intelligence, is teaming up with NVIDIA to develop cutting-edge artificial intelligence (AI) solutions. This collaboration aims to enhance the efficiency of medical research, streamline clinical trials, and improve patient outcomes through advanced AI workflows. By leveraging IQVIA's extensive healthcare data and NVIDIA's powerful AI platform, the two companies plan to create custom models and intelligent agents that will transform how new treatments are developed and delivered. The partnership was announced at the J.P. Morgan Conference in San Francisco and promises to bring significant advancements to the healthcare industry.
The healthcare sector is one of the most data-intensive industries globally, accounting for nearly 30% of the world’s data volume. Recognizing this, IQVIA intends to harness its vast information assets, analytics capabilities, and domain expertise—collectively known as IQVIA Connected Intelligence—to build language and multimodal foundational models. These models will be powered by NVIDIA’s AI Foundry service, enabling the creation of customized AI agents designed to perform specific tasks. For instance, these agents could assist in site selection, participant recruitment, and regulatory submissions during clinical trials, which typically span over a decade. By automating such processes, IQVIA aims to significantly reduce the time and complexity involved in bringing new drugs to market.
NVIDIA’s AI Foundry platform offers a suite of tools that will streamline the development of these AI agents. Key components include NVIDIA NIM microservices, Llama Nemotron and Cosmos Nemotron model families, reference workflows, and the NeMo platform for generative AI. Additionally, NVIDIA DGX Cloud provides dedicated capacity for developing and training these models. One notable application involves extracting valuable information from PDF files containing healthcare text, graphs, charts, and tables. This process, facilitated by NVIDIA’s AI Blueprint for multimodal PDF data extraction, can unlock previously inaccessible data, enhancing the training of AI models for domain-specific applications.
Beyond accelerating clinical trials, these AI agents have the potential to automate various time-consuming tasks, such as document generation and patient recruitment. This would allow healthcare professionals to focus more on strategic decision-making and direct patient care. Moreover, IQVIA remains committed to responsible AI use, ensuring that all AI-powered capabilities adhere to strict privacy standards, regulatory compliance, and patient safety protocols.
This innovative partnership between IQVIA and NVIDIA marks a significant step forward in the healthcare industry. By combining IQVIA’s unparalleled access to healthcare data and NVIDIA’s advanced AI technologies, the two companies are poised to revolutionize clinical research and treatment development. The resulting improvements in efficiency and patient outcomes will undoubtedly benefit both healthcare providers and patients alike, paving the way for a brighter future in medical innovation.